Armata Pharmaceuticals Inc. is a clinical-stage biotechnology firm headquartered in Marina del Rey, California, dedicated to pioneering bacteriophage-based therapies to combat the growing challenge of antibiotic-resistant infections. Leveraging cutting-edge technologies and extensive research capabilities, the company develops targeted treatment solutions that are essential in the management of infectious diseases. With a strong pipeline of innovative therapeutic candidates and strategic partnerships, Armata is strategically positioned as a leader in the urgent fight against antimicrobial resistance, aiming to improve patient outcomes and redefine standards of care in the global healthcare landscape.

NYSE MKT

USA

HEALTHCARE

BIOTECHNOLOGY

5005 MCCONNELL AVENUE, LOS ANGELES, CA, UNITED STATES, 90066

December

$250 Million

-$31.9 Million

0.0

-1.7

$0.00

0.0%

1.296